SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'FOL'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QHF_A_ACTA504_0 (CHORISMATE SYNTHASE) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 4 / 5 | SER A 188ARG A 119LEU A 124SER A 190 | NoneFOL A 301 (-3.0A)NoneFOL A 301 (-2.6A) | 1.24A | 2qhfA-4kmzA:undetectable | 2qhfA-4kmzA:18.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R2V_D_ACTD36_0 (GCN4 LEUCINE ZIPPER) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 3 / 3 | SER A 190TYR A 191HIS A 189 | FOL A 301 (-2.6A)FOL A 301 (-4.1A)None | 0.64A | 2r2vD-4kmzA:undetectable | 2r2vD-4kmzA:11.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R2V_D_ACTD36_0 (GCN4 LEUCINE ZIPPER) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 3 / 3 | SER A 174TYR A 175HIS A 173 | FOL A 301 (-2.8A)FOL A 301 (-4.1A)None | 0.66A | 2r2vD-4lrhA:undetectable | 2r2vD-4lrhA:19.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KMZ_A_FOLA301_0 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 12 / 12 | TYR A 76TYR A 101GLN A 116SER A 117TRP A 118ARG A 122PHE A 123HIS A 151ARG A 152TRP A 154TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-3.5A)FOL A 301 (-4.0A)FOL A 301 ( 4.4A)FOL A 301 ( 4.8A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.00A | 4kmzA-4kmzA:40.1 | 4kmzA-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KMZ_A_FOLA301_0 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 10 / 12 | TYR A 60TYR A 85GLN A 100SER A 101TRP A 102ARG A 106HIS A 135TRP A 138TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.5A)FOL A 301 (-4.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)NoneFOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.49A | 4kmzA-4lrhA:35.2 | 4kmzA-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KMZ_A_FOLA301_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 4 / 4 | ASP A 97ARG A 119TRP A 156SER A 190 | FOL A 301 (-2.8A)FOL A 301 (-3.0A)FOL A 301 (-3.7A)FOL A 301 (-2.6A) | 0.03A | 4kmzA-4kmzA:40.1 | 4kmzA-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KMZ_A_FOLA301_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 4 / 4 | ASP A 81ARG A 103TRP A 140SER A 174 | FOL A 301 (-2.7A)FOL A 301 (-3.2A)FOL A 301 (-3.6A)FOL A 301 (-2.8A) | 0.29A | 4kmzA-4lrhA:35.2 | 4kmzA-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 10 / 12 | TYR A 76PHE A 78ASP A 97TYR A 101GLN A 116ARG A 152GLY A 153TRP A 156TRP A 187SER A 190 | FOL A 301 (-3.8A)FOL A 301 ( 4.9A)FOL A 301 (-2.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)FOL A 301 (-4.0A)FOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-2.6A) | 0.82A | 4kn0A-4kmzA:36.9 | 4kn0A-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76PHE A 78ASP A 97TYR A 101GLN A 116TRP A 118ARG A 119ARG A 152GLY A 153TRP A 156TRP A 187 | FOL A 301 (-3.8A)FOL A 301 ( 4.9A)FOL A 301 (-2.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 (-4.0A)FOL A 301 (-4.0A)FOL A 301 (-3.7A)FOL A 301 (-3.5A) | 0.69A | 4kn0A-4kmzA:36.9 | 4kn0A-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 6 / 12 | PHE A 62ASP A 81GLY A 137TRP A 140TRP A 171SER A 174 | NoneFOL A 301 (-2.7A)FOL A 301 (-4.3A)FOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-2.8A) | 0.73A | 4kn0A-4lrhA:34.6 | 4kn0A-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 8 / 12 | TYR A 60PHE A 62ASP A 81TYR A 85GLN A 100TRP A 102ARG A 103TRP A 171 | FOL A 301 (-3.9A)NoneFOL A 301 (-2.7A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.7A) | 0.68A | 4kn0A-4lrhA:34.6 | 4kn0A-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 9 / 12 | TYR A 60PHE A 62ASP A 81TYR A 85TRP A 102ARG A 103GLY A 137TRP A 140TRP A 171 | FOL A 301 (-3.9A)NoneFOL A 301 (-2.7A)FOL A 301 (-4.1A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-4.3A)FOL A 301 (-3.6A)FOL A 301 (-3.7A) | 0.64A | 4kn0A-4lrhA:34.6 | 4kn0A-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 5 / 12 | ASP A 97ARG A 122HIS A 151GLY A 153TRP A 187 | FOL A 301 (-2.8A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)FOL A 301 (-3.5A) | 1.09A | 4kn2A-4kmzA:37.6 | 4kn2A-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 12 / 12 | ASP A 97THR A 98TYR A 101SER A 117TRP A 118ARG A 119HIS A 151GLY A 153TRP A 156TRP A 187SER A 190TYR A 191 | FOL A 301 (-2.8A)FOL A 301 ( 4.6A)FOL A 301 (-3.8A)FOL A 301 (-3.5A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)FOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-2.6A)FOL A 301 (-4.1A) | 0.32A | 4kn2A-4kmzA:37.6 | 4kn2A-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | ASP A 81ARG A 106HIS A 135GLY A 137TRP A 171 | FOL A 301 (-2.7A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.7A) | 0.94A | 4kn2A-4lrhA:34.8 | 4kn2A-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | ASP A 81THR A 82TYR A 85SER A 101TRP A 102ARG A 103HIS A 135GLY A 137TRP A 140TRP A 171SER A 174TYR A 175 | FOL A 301 (-2.7A)NoneFOL A 301 (-4.1A)FOL A 301 (-3.5A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-2.8A)FOL A 301 (-4.1A) | 0.44A | 4kn2A-4lrhA:34.8 | 4kn2A-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_A_LYAA304_2 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 4 / 4 | TYR A 76GLN A 116ARG A 152TRP A 154 | FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)None | 0.16A | 4kn2A-4kmzA:37.6 | 4kn2A-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_B_LYAB304_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 6 / 12 | ASP A 97ARG A 122HIS A 151ARG A 152GLY A 153TRP A 187 | FOL A 301 (-2.8A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)FOL A 301 (-4.0A)FOL A 301 (-3.5A) | 1.42A | 4kn2B-4kmzA:37.5 | 4kn2B-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_B_LYAB304_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 12 / 12 | ASP A 97THR A 98TYR A 101TRP A 118ARG A 119HIS A 151ARG A 152GLY A 153TRP A 156TRP A 187SER A 190TYR A 191 | FOL A 301 (-2.8A)FOL A 301 ( 4.6A)FOL A 301 (-3.8A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)FOL A 301 (-4.0A)FOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-2.6A)FOL A 301 (-4.1A) | 0.29A | 4kn2B-4kmzA:37.5 | 4kn2B-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_B_LYAB304_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | ASP A 81ARG A 106HIS A 135GLY A 137TRP A 171 | FOL A 301 (-2.7A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.7A) | 0.94A | 4kn2B-4lrhA:34.7 | 4kn2B-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_B_LYAB304_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 11 / 12 | ASP A 81THR A 82TYR A 85TRP A 102ARG A 103HIS A 135GLY A 137TRP A 140TRP A 171SER A 174TYR A 175 | FOL A 301 (-2.7A)NoneFOL A 301 (-4.1A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-2.8A)FOL A 301 (-4.1A) | 0.42A | 4kn2B-4lrhA:34.7 | 4kn2B-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 5 / 12 | ASP A 97ARG A 122HIS A 151GLY A 153TRP A 187 | FOL A 301 (-2.8A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)FOL A 301 (-3.5A) | 1.08A | 4kn2C-4kmzA:37.4 | 4kn2C-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 12 / 12 | ASP A 97THR A 98TYR A 101SER A 117TRP A 118ARG A 119HIS A 151GLY A 153TRP A 156TRP A 187SER A 190TYR A 191 | FOL A 301 (-2.8A)FOL A 301 ( 4.6A)FOL A 301 (-3.8A)FOL A 301 (-3.5A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)FOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-2.6A)FOL A 301 (-4.1A) | 0.28A | 4kn2C-4kmzA:37.4 | 4kn2C-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | ASP A 81ARG A 106HIS A 135GLY A 137TRP A 171 | FOL A 301 (-2.7A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.7A) | 0.93A | 4kn2C-4lrhA:34.7 | 4kn2C-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | ASP A 81THR A 82TYR A 85SER A 101TRP A 102ARG A 103HIS A 135GLY A 137TRP A 140TRP A 171SER A 174TYR A 175 | FOL A 301 (-2.7A)NoneFOL A 301 (-4.1A)FOL A 301 (-3.5A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-2.8A)FOL A 301 (-4.1A) | 0.44A | 4kn2C-4lrhA:34.7 | 4kn2C-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_C_LYAC304_2 (FOLATE RECEPTOR BETA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 3 / 3 | TYR A 76GLN A 116TRP A 154 | FOL A 301 (-3.8A)FOL A 301 ( 4.8A)None | 0.20A | 4kn2C-4kmzA:37.4 | 4kn2C-4kmzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KN2_C_LYAC304_2 (FOLATE RECEPTOR BETA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 3 / 3 | TYR A 60GLN A 100TRP A 138 | FOL A 301 (-3.9A)FOL A 301 (-4.3A)None | 0.45A | 4kn2C-4lrhA:34.7 | 4kn2C-4lrhA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_A_FOLA301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76TYR A 101GLN A 116SER A 117TRP A 118ARG A 119ARG A 122HIS A 151TRP A 154TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-3.5A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)NoneFOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.47A | 4lrhA-4kmzA:35.2 | 4lrhA-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_A_FOLA301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 5 / 12 | TYR A 101ARG A 119ARG A 122HIS A 151TRP A 150 | FOL A 301 (-3.8A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)None | 1.45A | 4lrhA-4kmzA:35.2 | 4lrhA-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_A_FOLA301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60TYR A 85GLN A 100SER A 101TRP A 102ARG A 103ARG A 106HIS A 135LYS A 136TRP A 138TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.5A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.00A | 4lrhA-4lrhA:40.3 | 4lrhA-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_A_FOLA301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | TYR A 85ARG A 103ARG A 106HIS A 135TRP A 134 | FOL A 301 (-4.1A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)None | 1.33A | 4lrhA-4lrhA:40.3 | 4lrhA-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_A_FOLA301_1 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 3 / 3 | ASP A 97TRP A 156SER A 190 | FOL A 301 (-2.8A)FOL A 301 (-3.7A)FOL A 301 (-2.6A) | 0.25A | 4lrhA-4kmzA:35.2 | 4lrhA-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_A_FOLA301_1 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 3 / 3 | ASP A 81TRP A 140SER A 174 | FOL A 301 (-2.7A)FOL A 301 (-3.6A)FOL A 301 (-2.8A) | 0.00A | 4lrhA-4lrhA:40.3 | 4lrhA-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76TYR A 101GLN A 116SER A 117ARG A 119ARG A 122HIS A 151TRP A 154TRP A 156TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-3.5A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)NoneFOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.66A | 4lrhB-4kmzA:35.3 | 4lrhB-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 5 / 12 | TYR A 101ARG A 119ARG A 122HIS A 151TRP A 150 | FOL A 301 (-3.8A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)None | 1.28A | 4lrhB-4kmzA:35.3 | 4lrhB-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 6 / 12 | GLN A 100ARG A 106HIS A 135LYS A 136TRP A 138TRP A 171 | FOL A 301 (-4.3A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.7A) | 1.39A | 4lrhB-4lrhA:37.0 | 4lrhB-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60TYR A 85GLN A 100SER A 101ARG A 103ARG A 106HIS A 135LYS A 136TRP A 138TRP A 140TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.5A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.58A | 4lrhB-4lrhA:37.0 | 4lrhB-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | TYR A 85ARG A 103ARG A 106HIS A 135TRP A 134 | FOL A 301 (-4.1A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)None | 1.28A | 4lrhB-4lrhA:37.0 | 4lrhB-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_1 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 3 / 3 | ASP A 97TRP A 118SER A 190 | FOL A 301 (-2.8A)FOL A 301 (-4.0A)FOL A 301 (-2.6A) | 0.57A | 4lrhB-4kmzA:35.3 | 4lrhB-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_B_FOLB301_1 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 3 / 3 | ASP A 81TRP A 102SER A 174 | FOL A 301 (-2.7A)FOL A 301 (-4.2A)FOL A 301 (-2.8A) | 0.55A | 4lrhB-4lrhA:37.0 | 4lrhB-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_C_FOLC301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 12 / 12 | TYR A 76ASP A 97TYR A 101GLN A 116TRP A 118ARG A 119ARG A 122HIS A 151TRP A 154TRP A 156TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-2.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)NoneFOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.49A | 4lrhC-4kmzA:34.7 | 4lrhC-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_C_FOLC301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60ASP A 81TYR A 85GLN A 100TRP A 102ARG A 103ARG A 106HIS A 135TRP A 138TRP A 140TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-2.7A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)NoneFOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.25A | 4lrhC-4lrhA:37.2 | 4lrhC-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_C_FOLC301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | TYR A 85ARG A 103ARG A 106HIS A 135TRP A 134 | FOL A 301 (-4.1A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)None | 1.33A | 4lrhC-4lrhA:37.2 | 4lrhC-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_D_FOLD301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76ASP A 97TYR A 101GLN A 116SER A 117TRP A 118ARG A 119ARG A 122TRP A 154TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-2.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-3.5A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)NoneFOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.49A | 4lrhD-4kmzA:34.8 | 4lrhD-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_D_FOLD301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 6 / 12 | ASP A 81GLN A 100ARG A 106LYS A 136TRP A 138TRP A 171 | FOL A 301 (-2.7A)FOL A 301 (-4.3A)FOL A 301 (-3.8A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.7A) | 1.44A | 4lrhD-4lrhA:37.2 | 4lrhD-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_D_FOLD301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60ASP A 81TYR A 85GLN A 100SER A 101TRP A 102ARG A 103ARG A 106LYS A 136TRP A 138TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-2.7A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.5A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.45A | 4lrhD-4lrhA:37.2 | 4lrhD-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_D_FOLD301_1 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 3 / 3 | HIS A 151TRP A 156SER A 190 | FOL A 301 (-3.9A)FOL A 301 (-3.7A)FOL A 301 (-2.6A) | 0.24A | 4lrhD-4kmzA:34.8 | 4lrhD-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_D_FOLD301_1 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 3 / 3 | HIS A 135TRP A 140SER A 174 | FOL A 301 (-4.1A)FOL A 301 (-3.6A)FOL A 301 (-2.8A) | 0.17A | 4lrhD-4lrhA:37.2 | 4lrhD-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_E_FOLE301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76ASP A 97TYR A 101GLN A 116TRP A 118ARG A 119ARG A 122HIS A 151TRP A 156TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-2.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)FOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.49A | 4lrhE-4kmzA:35.0 | 4lrhE-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_E_FOLE301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60ASP A 81TYR A 85GLN A 100TRP A 102ARG A 103ARG A 106HIS A 135LYS A 136TRP A 140TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-2.7A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.0A)FOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.34A | 4lrhE-4lrhA:37.1 | 4lrhE-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_F_FOLF301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76TYR A 101GLN A 116ARG A 119ARG A 122HIS A 151GLY A 153TRP A 154TRP A 156TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.49A | 4lrhF-4kmzA:34.8 | 4lrhF-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_F_FOLF301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 5 / 12 | TYR A 101ARG A 119ARG A 122HIS A 151TRP A 150 | FOL A 301 (-3.8A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)None | 1.46A | 4lrhF-4kmzA:34.8 | 4lrhF-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_F_FOLF301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60TYR A 85GLN A 100ARG A 103ARG A 106HIS A 135LYS A 136GLY A 137TRP A 138TRP A 140TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.0A)FOL A 301 (-4.3A)NoneFOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.27A | 4lrhF-4lrhA:37.6 | 4lrhF-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_F_FOLF301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | TYR A 85ARG A 103ARG A 106HIS A 135TRP A 134 | FOL A 301 (-4.1A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)None | 1.33A | 4lrhF-4lrhA:37.6 | 4lrhF-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_F_FOLF301_1 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 3 / 3 | ASP A 97TRP A 118SER A 190 | FOL A 301 (-2.8A)FOL A 301 (-4.0A)FOL A 301 (-2.6A) | 0.61A | 4lrhF-4kmzA:34.8 | 4lrhF-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_F_FOLF301_1 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 3 / 3 | ASP A 81TRP A 102SER A 174 | FOL A 301 (-2.7A)FOL A 301 (-4.2A)FOL A 301 (-2.8A) | 0.58A | 4lrhF-4lrhA:37.6 | 4lrhF-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_G_FOLG301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76TYR A 101GLN A 116TRP A 118ARG A 119ARG A 122GLY A 153TRP A 156TRP A 187SER A 190TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-4.0A)FOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-2.6A)FOL A 301 (-4.1A) | 0.56A | 4lrhG-4kmzA:35.0 | 4lrhG-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_G_FOLG301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60TYR A 85GLN A 100TRP A 102ARG A 103ARG A 106LYS A 136GLY A 137TRP A 140TRP A 171SER A 174TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.0A)FOL A 301 (-4.3A)FOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-2.8A)FOL A 301 (-4.1A) | 0.36A | 4lrhG-4lrhA:37.1 | 4lrhG-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_H_FOLH301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 11 / 12 | TYR A 76TYR A 101GLN A 116TRP A 118ARG A 119ARG A 122HIS A 151TRP A 154TRP A 156TRP A 187TYR A 191 | FOL A 301 (-3.8A)FOL A 301 (-3.8A)FOL A 301 ( 4.8A)FOL A 301 (-4.0A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)NoneFOL A 301 (-3.7A)FOL A 301 (-3.5A)FOL A 301 (-4.1A) | 0.47A | 4lrhH-4kmzA:35.7 | 4lrhH-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_H_FOLH301_0 (FOLATE RECEPTORALPHA) |
4kmz | FOLATE RECEPTOR BETA (Homosapiens) | 5 / 12 | TYR A 101ARG A 119ARG A 122HIS A 151TRP A 150 | FOL A 301 (-3.8A)FOL A 301 (-3.0A)FOL A 301 ( 4.4A)FOL A 301 (-3.9A)None | 1.38A | 4lrhH-4kmzA:35.7 | 4lrhH-4kmzA:77.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_H_FOLH301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 12 / 12 | TYR A 60TYR A 85GLN A 100TRP A 102ARG A 103ARG A 106HIS A 135LYS A 136TRP A 138TRP A 140TRP A 171TYR A 175 | FOL A 301 (-3.9A)FOL A 301 (-4.1A)FOL A 301 (-4.3A)FOL A 301 (-4.2A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)FOL A 301 (-4.0A)NoneFOL A 301 (-3.6A)FOL A 301 (-3.7A)FOL A 301 (-4.1A) | 0.17A | 4lrhH-4lrhA:37.4 | 4lrhH-4lrhA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LRH_H_FOLH301_0 (FOLATE RECEPTORALPHA) |
4lrh | FOLATE RECEPTORALPHA (Homosapiens) | 5 / 12 | TYR A 85ARG A 103ARG A 106HIS A 135TRP A 134 | FOL A 301 (-4.1A)FOL A 301 (-3.2A)FOL A 301 (-3.8A)FOL A 301 (-4.1A)None | 1.29A | 4lrhH-4lrhA:37.4 | 4lrhH-4lrhA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X3U_B_SVRB102_1 (CHROMOBOX PROTEINHOMOLOG 7) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 3 / 3 | LYS A 36ARG A 26VAL A 22 | FOL A 201 (-2.9A)NoneNone | 0.90A | 4x3uA-4z7fA:undetectable4x3uB-4z7fA:undetectable | 4x3uA-4z7fA:16.864x3uB-4z7fA:16.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_A_FOLA201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 12 / 12 | LEU A 35LYS A 36SER A 38ASP A 64MET A 68ALA A 74TYR A 76PHE A 80THR A 81ASN A 117ARG A 142LYS A 145 | FOL A 201 (-4.4A)FOL A 201 (-2.9A)FOL A 201 (-3.5A)FOL A 201 (-2.8A)FOL A 201 (-3.2A)FOL A 201 (-3.6A)FOL A 201 (-3.8A)FOL A 201 (-3.9A)FOL A 201 (-4.5A)FOL A 201 (-3.7A)FOL A 201 (-3.9A)FOL A 201 (-3.7A) | 0.03A | 4z7fA-4z7fA:33.7 | 4z7fA-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_B_FOLB201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 11 / 12 | ASP A 64MET A 68ALA A 74TYR A 76PHE A 77PHE A 80THR A 81ASN A 117THR A 121ARG A 142LYS A 145 | FOL A 201 (-2.8A)FOL A 201 (-3.2A)FOL A 201 (-3.6A)FOL A 201 (-3.8A)NoneFOL A 201 (-3.9A)FOL A 201 (-4.5A)FOL A 201 (-3.7A)FOL A 201 (-2.6A)FOL A 201 (-3.9A)FOL A 201 (-3.7A) | 0.60A | 4z7fB-4z7fA:26.7 | 4z7fB-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_C_FOLC201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 8 / 12 | SER A 38ALA A 74PHE A 77PHE A 80THR A 81ASN A 117THR A 121LYS A 145 | FOL A 201 (-3.5A)FOL A 201 (-3.6A)NoneFOL A 201 (-3.9A)FOL A 201 (-4.5A)FOL A 201 (-3.7A)FOL A 201 (-2.6A)FOL A 201 (-3.7A) | 0.86A | 4z7fC-4z7fA:27.7 | 4z7fC-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_C_FOLC201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 9 / 12 | SER A 38ALA A 74PHE A 77PHE A 80THR A 81THR A 121LEU A 125ARG A 142LYS A 145 | FOL A 201 (-3.5A)FOL A 201 (-3.6A)NoneFOL A 201 (-3.9A)FOL A 201 (-4.5A)FOL A 201 (-2.6A)NoneFOL A 201 (-3.9A)FOL A 201 (-3.7A) | 0.59A | 4z7fC-4z7fA:27.7 | 4z7fC-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_D_FOLD201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 6 / 11 | LYS A 36SER A 38ASP A 64MET A 68ALA A 74LYS A 145 | FOL A 201 (-2.9A)FOL A 201 (-3.5A)FOL A 201 (-2.8A)FOL A 201 (-3.2A)FOL A 201 (-3.6A)FOL A 201 (-3.7A) | 1.32A | 4z7fD-4z7fA:27.2 | 4z7fD-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_D_FOLD201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 8 / 11 | SER A 38ASP A 64MET A 68ALA A 74ASN A 83ASN A 117THR A 121LYS A 145 | FOL A 201 (-3.5A)FOL A 201 (-2.8A)FOL A 201 (-3.2A)FOL A 201 (-3.6A)NoneFOL A 201 (-3.7A)FOL A 201 (-2.6A)FOL A 201 (-3.7A) | 0.97A | 4z7fD-4z7fA:27.2 | 4z7fD-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_E_FOLE201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 6 / 9 | MET A 68ALA A 74PHE A 80THR A 81ASN A 117THR A 121 | FOL A 201 (-3.2A)FOL A 201 (-3.6A)FOL A 201 (-3.9A)FOL A 201 (-4.5A)FOL A 201 (-3.7A)FOL A 201 (-2.6A) | 0.86A | 4z7fE-4z7fA:21.2 | 4z7fE-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_E_FOLE201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 6 / 9 | SER A 38MET A 68ALA A 74PHE A 80ASN A 117THR A 121 | FOL A 201 (-3.5A)FOL A 201 (-3.2A)FOL A 201 (-3.6A)FOL A 201 (-3.9A)FOL A 201 (-3.7A)FOL A 201 (-2.6A) | 1.08A | 4z7fE-4z7fA:21.2 | 4z7fE-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Z7F_E_FOLE201_0 (FOLATE ECFTRANSPORTER) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 6 / 9 | SER A 38MET A 68TYR A 76PHE A 80ASN A 117THR A 121 | FOL A 201 (-3.5A)FOL A 201 (-3.2A)FOL A 201 (-3.8A)FOL A 201 (-3.9A)FOL A 201 (-3.7A)FOL A 201 (-2.6A) | 1.20A | 4z7fE-4z7fA:21.2 | 4z7fE-4z7fA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D0Y_B_FOLB201_0 (CONSERVEDHYPOTHETICALMEMBRANE PROTEIN) |
4z7f | FOLATE ECFTRANSPORTER (Enterococcusfaecalis) | 5 / 12 | LEU A 35ASP A 64PHE A 80THR A 81LYS A 145 | FOL A 201 (-4.4A)FOL A 201 (-2.8A)FOL A 201 (-3.9A)FOL A 201 (-4.5A)FOL A 201 (-3.7A) | 0.80A | 5d0yB-4z7fA:22.9 | 5d0yB-4z7fA:33.66 |